Effect of cardiac resynchronization therapy on cardiotrophin-1 circulating levels in patients with heart failure

[1]  Jeroen J. Bax,et al.  Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy. , 2011, American heart journal.

[2]  G. Limongelli,et al.  Novel insights into the role of cardiotrophin-1 in cardiovascular diseases. , 2009, Journal of molecular and cellular cardiology.

[3]  Luigi Ascione,et al.  Effects of global longitudinal strain and total scar burden on response to cardiac resynchronization therapy in patients with ischaemic dilated cardiomyopathy , 2009, European journal of heart failure.

[4]  D. Kass,et al.  Cardiac Resynchronization Therapy Corrects Dyssynchrony-Induced Regional Gene Expression Changes on a Genomic Level , 2008, Circulation: Cardiovascular Genetics.

[5]  W. Tang,et al.  The year in heart failure. , 2008, Journal of the American College of Cardiology.

[6]  W. Wijns,et al.  Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. , 2008, Journal of the American College of Cardiology.

[7]  S. Nagueh.  Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. , 2008, Journal of the American College of Cardiology.

[8]  G. Di Salvo,et al.  Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study. , 2007, European heart journal.

[9]  M. Horie,et al.  Plasma level of cardiotrophin‐1 as a prognostic predictor in patients with chronic heart failure , 2007, European journal of heart failure.

[10]  G. Di Salvo,et al.  Effect of dynamic myocardial dyssynchrony on mitral regurgitation during supine bicycle exercise stress echocardiography in patients with idiopathic dilated cardiomyopathy and 'narrow' QRS. , 2007, European heart journal.

[11]  M. Volpe,et al.  Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin , 2007, European journal of heart failure.

[12]  David D Spragg,et al.  Pathobiology of left ventricular dyssynchrony and resynchronization. , 2006, Progress in cardiovascular diseases.

[13]  K. Lappegård,et al.  Anti‐Inflammatory Effect of Cardiac Resynchronization Therapy , 2006, Pacing and clinical electrophysiology : PACE.

[14]  L. Saccá,et al.  Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium. , 2006, European heart journal.

[15]  F. Muenzel,et al.  Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue. , 2005, American journal of physiology. Endocrinology and metabolism.

[16]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[17]  M. Weyand,et al.  Augmented Expression of Cardiotrophin-1 in Failing Human Hearts Is Accompanied by Diminished Glycoprotein 130 Receptor Protein Abundance , 2002, Circulation.

[18]  A. Michelucci,et al.  Increased Cardiac Sympathetic Activity and Insulin-Like Growth Factor-I Formation Are Associated With Physiological Hypertrophy in Athletes , 2001, Circulation research.

[19]  K. Nakao,et al.  Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy. , 2001, Journal of the American College of Cardiology.

[20]  I. Kishimoto,et al.  The heart is a source of circulating cardiotrophin-1 in humans. , 2000, Biochemical and biophysical research communications.

[21]  M. Redfield,et al.  Augmented cardiac cardiotrophin-1 in experimental congestive heart failure. , 2000, Circulation.

[22]  J. Heath,et al.  Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy , 1996, The Journal of Biological Chemistry.

[23]  K. Chien,et al.  Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Eriksson.  Heart failure: a growing public health problem , 1995, Journal of internal medicine.